Key result
Point-of-care hs-cTnI linked to ~43-minute shorter emergency department length of stay vs laboratory testing.
Why the study?
The study was conducted to compare actual ED length of stay using laboratory-based hs-cTnI testing with the potential length of stay that could result from using point-of-care hs-cTnI tests.
Does point-of-care hs-cTnI testing reduce emergency department length of stay in patients presenting with suspected myocardial infarction?
Observational (n=429)
No
Does point-of-care hs-cTnI testing reduce emergency department length of stay in patients presenting with suspected myocardial infarction?
Answers are grounded in this paper and cite their sources.
Implementing point-of-care high-sensitivity troponin assays in the emergency department can significantly reduce patient length of stay, improving hospital throughput.
OBJECTIVE: To compare actual ED length of stay (LOS) using laboratory-based high-sensitivity cardiac troponin I (hs-cTnI) testing with the potential LOS that could result from using point-of-care (POC) hs-cTnI tests. METHODS: Baseline hs-cTnI tests were performed on the same blood sample in the laboratory (Access hsTnI assay) and in the ED (Atellica VTLi POC assay). Actual and potential LOS were compared for patients who were discharged after having a baseline laboratory hs-cTnI test only. Total LOS incorporated time from arrival to blood sample collection, blood sampling to result availability and result availability to discharge. For potential LOS, the blood sampling to result availability time with POC use was fixed at 10 min (2-min preparation and 8-min test-processing). The laboratory blood sampling to result availability time was from blood sample collection to result uploading on the pathology computer system. For the study, it was assumed that this was the only LOS component that would differ with POC use. Invalid POC result rates were monitored. RESULTS: For 152 patients discharged after having a single baseline laboratory hs-cTnI test, the median actual LOS was 195 (interquartile range [IQR]: 152-319) min, which included a median laboratory blood-sampling-to-result-availability time of 48 (IQR: 41-59) min. The potential LOS from POC use was 157 (IQR: 103-282) min, which included the fixed 10-min blood-sampling-to-result-availability time. The mean actual-potential LOS difference was 43 (95% confidence interval [CI]: 40-46) min. The POC invalid result rate was 11%. CONCLUSION: The Atellica VTLi could deliver a mean ED LOS reduction of 43-min per patient for those discharged after a single baseline hs-cTnI test. Use in actual practice and the invalid result rate require further evaluation.
No takes yet. Share an insight, caveat, or question.
Meek et al. (2025) conducted an observational in Suspected myocardial infarction (n=429). Point-of-care high-sensitivity cardiac troponin I (hs-cTnI) assay (Atellica VTLi) vs. Laboratory-based hs-cTnI testing (Access hsTnI assay) was evaluated on Difference between actual and potential emergency department length of stay (LOS) for patients discharged after a single baseline test (MD 43, 95% CI 40-46). Use of the Atellica VTLi point-of-care high-sensitivity cardiac troponin I assay could reduce emergency department length of stay by a mean of 43 minutes compared to laboratory testing.
Synapse has enriched 10 related papers. Consider them for comparative context: